The History of Collagenase Clostridium Histolyticum.

  title={The History of Collagenase Clostridium Histolyticum.},
  author={Kevin K Yang and Nelson Bennett},
  journal={Sexual medicine reviews},
  volume={3 4},
INTRODUCTION After its U.S. FDA approval in 2013, Collagenase Clostridium histolyticum (CCh) has seen increasing use as a nonoperative treatment for Peyronie's disease (PD). We review the history of CCh and trials that led to its adoption. AIM To provide a historical and contemporary context for the evolution of Collagenase Clostridium histolyticum as a treatment modality for Peyronie's disease. METHODS A comprehensive search of peer-reviewed literature was performed pertaining to CCh and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications referenced by this paper.
Showing 1-10 of 90 references

Peyronie’s disease. BJU Int 2014;113:704–13

  • TF Lue, F Giuliano, F Montorsi, RC Rosen, KE Andersson
  • 2014

Similar Papers

Loading similar papers…